BILIBILI-W(09626.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 209.78 million, turned profitable from a loss YoY

NewTimeSpace News: May 19, 2026, BILIBILI-W(09626.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 7.47 billion, increased by 6.69% YoY; Net Profit stood at CNY 202 million, turned profitable from a loss YoY; Profit Attributable to Shareholders stood at CNY 209.78 million, turned profitable from a loss YoY; Basic Earnings Per Share (EPS) stood at CNY 0.5.

In terms of profitability, BILIBILI-W Gross Profit changed from CNY 2.54 billion in the same period last year to CNY 2.77 billion in the current period, increased by CNY 234.14 million; gross profit margin changed from 36.26% in the same period last year to 37.11% in the current period, increased by 0.86 percentage points; net profit changed from loss of CNY 10.68 million in the same period last year to CNY 202 million in the current period, increased by CNY 212.67 million; net profit margin changed from -0.15% in the same period last year to 2.7% in the current period, increased by 2.85 percentage points.

In terms of earnings quality, BILIBILI-W Operating Profit changed from CNY 15.01 million in the same period last year to CNY 166.76 million in the current period, increased by CNY 151.75 million; Operating Profit Margin changed from 0.21% in the same period last year to 2.23% in the current period, increased by 2.02 percentage points.

In terms of financial soundness, BILIBILI-W Debt-to-Asset Ratio changed from 56.79% in the same period last year to 62.32% in the current period, increased by 5.53 percentage points; Total Equity changed from CNY 14.38 billion in the same period last year to CNY 15.609 billion in the current period, increased by CNY 1.23 billion; Current Liabilities changed from CNY 15.1 billion in the same period last year to CNY 20.57 billion in the current period, increased by CNY 5.47 billion.

In terms of R&D investment focus, BILIBILI-W R&D Expenses changed from CNY 841.48 million in the same period last year to CNY 921.11 million in the current period, increased by CNY 79.63 million; R&D to Total Revenue Ratio changed from 12.02% in the same period last year to 12.33% in the current period, increased by 0.31 percentage points.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.